Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Glucagon, Glucose Monitoring, Insulin Delivery Aug 24 | 2021Gvoke Kit Receives FDA Approval; Medtronic Q2 '21 Earnings UpdatePurchase Blast
$599
Posted in: Glucagon, Other, SGLT2i Aug 23 | 2021Lexicon and Amarin Present Data at ESC 2021Purchase Blast
$599
Posted in: Other Aug 17 | 2021Does Lifescan’s Expanded Partnership with Cecelia Health Signal a New Business Model to Set Up for an Acquisition by Livongo?Purchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Aug 16 | 2021Lyumjev Approved for Insulin Pump Use; Dario and Nemaura Q2 '21 Earnings Updates; CHMP Agenda August 16-19Purchase Blast
$599
Posted in: Glucagon, Glucose Monitoring Aug 13 | 2021Xeris Expanded Payor Coverage; Movano Q2 '21 Earnings UpdatePurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Glucagon, Glucose Monitoring, Other Aug 12 | 2021New Non-invasive CGM Startup Raises $11.7M in Series B; Zealand, Mannkind, and Metacrine Q2 '21 Earnings Updates; Integrity Applications Reverse Stock SplitPurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 10 | 2021Lifescan and Fitbit Diabetes Collaboration; Sigilon Q2 '21 Earnings UpdatePurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Other Aug 09 | 2021Viatris and Senseonics Q2 '21 Earnings Updates; Forxiga CKD EU Approval; GoodRx and BI Patient Access Initiative; Diamyd EU Patent Granted; New Glooko CTOPurchase Blast
$599
Posted in: Glucagon, Insulin Delivery, Other Aug 06 | 2021Xeris, Amarin, Regeneron, and BD Q2 '21 Earnings UpdatesPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Aug 05 | 2021Omnipod 5 Delayed; Insulet, Provention Bio, and Bayer Q2 '21 Earnings UpdatesPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Aug 04 | 2021Tandem, Ionis, Esperion, and Amgen Q2 '21 Earnings Updates; Dario Gains National Digital Behavioral Health ContractPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Other Aug 04 | 2021Wegovy Launch Impresses; Guidance Raised; Novo Q2 '21 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 02 | 2021Libre 2 iOS App Cleared in US; Novartis Pelacarsen CVOT Reaches 50% EnrollmentPurchase Blast
$599
Posted in: DPP-IVi, Dual/triple agonist, Other, SGLT2i Jul 30 | 2021Lexicon, Merck, and Intercept Q2 '21 Earnings UpdatePurchase Blast
Get the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
